Autophagy- An emerging target for melanoma therapy

Area of Science:

• Oncology
• Cellular Biology
• Molecular Medicine

Background:

• Melanoma is a deadly skin cancer with high metastatic potential and poor survival rates for advanced cases.
• Therapy resistance is a major challenge in melanoma treatment, limiting clinical efficacy.
• Autophagy, a cellular recycling process, plays a complex role in cancer, acting as tumor-suppressive early on and tumor-promoting in established malignancies.

Purpose of the Study:

• To review the current understanding of autophagy's role in melanoma malignancy, particularly in the context of therapy resistance.
• To explore how melanoma cells exploit autophagy to survive and progress despite treatment.
• To evaluate emerging therapeutic strategies targeting autophagy modulation for melanoma treatment.

Main Methods:

• Literature review of studies on autophagy in melanoma.
• Analysis of mechanisms by which melanoma cells utilize autophagy for stress adaptation.
• Evaluation of preclinical and clinical data on autophagy-modulating therapies.

Main Results:

• Melanoma cells activate autophagy to cope with drug-induced and metabolic stress, conferring resistance to various therapies.
• Autophagy promotes melanoma cell survival, progression, and metastasis in advanced stages.
• Targeting autophagy presents a promising avenue for overcoming therapy resistance in melanoma.

Conclusions:

• Autophagy is a key mechanism enabling melanoma cells to resist treatment and drive disease progression.
• Modulating autophagy holds significant therapeutic potential for improving outcomes in metastatic melanoma.
• Further research into autophagy pathways is crucial for developing effective anti-melanoma strategies.